Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Receivables: 2022-2023

Historic Receivables for Dianthus Therapeutics (DNTH) over the last 2 years, with Dec 2023 value amounting to $494,000.

  • Dianthus Therapeutics' Receivables rose 85.87% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 54.25%. This contributed to the annual value of $494,000 for FY2023, which is 91.18% down from last year.
  • As of FY2023, Dianthus Therapeutics' Receivables stood at $494,000, which was down 91.18% from $5.6 million recorded in FY2022.
  • Dianthus Therapeutics' 5-year Receivables high stood at $5.6 million for FY2022, and its period low was $494,000 during FY2023.
  • In the last 2 years, Dianthus Therapeutics' Receivables had a median value of $3.0 million in 2022 and averaged $3.0 million.
  • Data for Dianthus Therapeutics' Receivables shows a maximum YoY tumbled of 91.18% (in 2023) over the last 5 years.
  • Dianthus Therapeutics' Receivables (Yearly) stood at $5.6 million in 2022, then slumped by 91.18% to $494,000 in 2023.